Abstract
Background
Psoriasis affects 2–4% of the population, with the most common clinical type being plaque psoriasis. The linear form of psoriasis is very rare. The literature on linear psoriasis (LP) consists of only case reports, and data are few.
Objective
This study aimed to better understand LP in a large-scale study.
Patients and Methods
We retrospectively retrieved the medical records from 14 French medical centers of patients newly diagnosed clinically with LP, with or without the support of histology, between 1 February and 31 July 2015. For each case, we assessed the clinical features, treatments and treatment efficacy.
Results
In total, 30 cases of LP (mean age 26.8 years, 13 males) were reported. Mean age at onset of LP was 20.0 years, with 18 developing LP in childhood. Ten patients had a family history of psoriasis, and two had psoriatic arthritis. A total of 19 cases were linear at onset, with concomitant classical psoriasis; these were termed “superimposed” LP. The remaining 11 cases were not associated with classical psoriasis and were termed “isolated” LP. In four of the superimposed cases, LP developed when the patient was receiving systemic treatment: methotrexate (n = 2), etanercept (n = 1) or infliximab (n = 1). Topical steroids were effective in 76% of cases in which they were used, and systemic treatment was effective in < 66%. Treatments were less effective in LP than in classical psoriasis.
Discussion
We identified a wide range of LP, with two profiles: isolated LP and superimposed LP. Topical treatment usually evoked clinical response, with relative resistance to systemic therapy. Methotrexate and anti-tumor necrosis factor (TNF)-α therapies can possibly unmask LP.
Similar content being viewed by others
References
Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Investig Dermatol. 2013;133(2):377–85.
Al-Fouzan AS, Hassab-el-Naby HM, Nanda A. Congenital linear psoriasis: a case report. Pediatr Dermatol. 1990;7:303–6.
Chien P Jr, Rosenman K, Cheung W, et al. Linear psoriasis. Dermatol Online J. 2009;15:4.
Kanodia S, Shukla S, Saxena V, et al. Linear psoriasis. Indian J Dermatol Venereol Leprol. 2006;72:398.
de Figueiras DA, Cauas RC, Takano DM, et al. Linear psoriasis: case report on three year old child. An Bras Dermatol. 2015;90:194–6.
Galluzzo M, Talamonti M, Di Stefani A, et al. Linear psoriasis following the typical distribution of the sciatic nerve. J Dermatol Case Rep. 2015;9:6–11.
Ozkaya-Bayazit E, Akasya E, Büyükbabani N, et al. Pustular psoriasis with striking linear pattern. J Am Acad Dermatol. 2000;42:329–31.
Sfia M, Roth-Mall B, Tortel MC, et al. Psoriasis blaschko-linéaire révélé par un traitement par infliximab (Remicade®). Ann Dermatol Venereol. 2009;136:898–903.
Brinca A, Santiago F, Serra D, et al. A linear psoriasis—a case report. Case Rep Dermatol. 2011;3:8–12.
Saraswat A, Sandhu K, Shukla R, et al. Unilateral linear psoriasis with palmoplantar, nail, and scalp involvement. Pediatr Dermatol. 2004;21:70–3.
Arnold AW, Happle R, Itin PH. Superimposed linear psoriasis unmasked by therapy with adalimumab. Eur J Dermatol. 2010;20:573–4.
Lenormand C, Cribier B, Lipsker D. Blaschko-linear manifestations of polygenic inflammatory diseases: analysis of 17 cases. Eur J Dermatol. 2013;23:671–6.
Seitz CS, Garbaraviciene J, Bröcker EB, et al. Superimposed linear psoriasis: differential therapeutic response of linear and nonlinear lesions. Clin Exp Dermatol. 2009;34:e177–9.
Kira M, Katayama I. Superimposed linear psoriasis. J Dermatol. 2010;37:1063–5.
Takahashi H, Ishida-Yamamoto A, Iizuka H. Linear psoriasis treated with topical glucocorticoid and active vitamin D3 ointments. J Dermatol. 2016;43:1438–9.
Deswysen AC, Marota L, Roquet-Gravy PP. Induction d’un psoriasis blaschko-linéaire sous Humira®, en résolution sous Stelara®. Ann Dermatol Venerol. 2011;138:A176–7.
Kanoh H, Ichihashi N, Kamiya H, et al. Linear pustular psoriasis that developed in a patient with generalized pustular psoriasis. J Am Acad Dermatol. 1998;39:635–7.
Colombo L, Marconi M, Mapelli ET, et al. Superimposed linear psoriasis: low effectiveness of biologic therapy. G Ital Dermatol Venereol. 2011;146:311–3.
Dohi Happle R, Lecture Memorial. New aspects of cutaneous mosaicism. J Dermatol. 2002;29:681–92.
Happle R. A rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol. 1997;133:1505–9.
Lipsker D, Cribier B, Girard-Lemaire F, et al. Genetic mosaicism in an acquired inflammatory dermatosis following the lines of Blaschko. Arch Dermatol. 2000;136:805–7.
Happle R. Superimposed segmental manifestation of both rare and common cutaneous disorders: a new paradigm. Actas Dermosifiliogr. 2009;100(Suppl 1):77–85.
Al Rohil RN, Leung D, Carlson JA. Congenital vulnerability of cutaneous segments arising from skin mosaicism: A genetic basis for locus minoris resistentiae. Clin Dermatol. 2014;32:577–91.
Cribier B. Psoriasis: formes rares ou inhabituelles. Ann Dermatol Venerol. 2012;139:S39–45.
Grosshans EM. Acquired blaschkolinear dermatoses. Am J Med Genet. 1999;85:334–7.
Ferreira FR, Di Chiacchio NG, Alvarenga ML, et al. Involucrin in the differential diagnosis between linear psoriasis and inflammatory linear verrucous epidermal nevus: a report of one case. An Bras Dermatol. 2013;88:604–7.
Akelma AZ, Cizmeci MN, Kanburoglu MK, et al. A diagnostic dilemma: inflammatory linear verrucous epidermal nevus versus linear psoriasis. J Pediatr. 2013;162:879.
Happle R. Superimposed segmental manifestation of polygenic skin disorders. J Am Acad Dermatol. 2007;57:690–9.
Happle R. Somatic recombination may explain linear psoriasis. J Med Genet. 1991;28:337.
Happle R. Loss of heterozygosity in human skin. J Am Acad Dermatol. 1999;41:143–64.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Funding
No sources of funding were used to conduct this study or prepare this manuscript.
Conflicts of interest
MS, FB, CL, A-CB, EE, AP, EB, J-PL, M-AR, AA, DJ, NB, VD, CB, ML, CC and EM have no conflicts of interest that are directly relevant to the content of this study.
Rights and permissions
About this article
Cite this article
Say, M., Boralévi, F., Lenormand, C. et al. Clinical and Therapeutic Aspects of Linear Psoriasis: A Study of 30 Cases. Am J Clin Dermatol 19, 609–615 (2018). https://doi.org/10.1007/s40257-018-0354-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40257-018-0354-9